Professional
Added to YB: 2025-07-10
Pitch date: 2025-07-09
IPA [neutral]
MindWalk Holdings Corp.
-27.08%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology.
Market Cap
$94.2M
Pitch Price
$1.92
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.76
P/E
-5.44
EV/Sales
5.55
Sector
Life Sciences Tools and Services
Category
growth
Pernas Research More Research Needed On: ImmunoPrecise Antibodies Ltd.
IPA more research needed: CRO with AI biotherapeutics segment. 2022 BioStrand acquisition added epitope mapping expertise/data. Integrates wet-lab with computational testing to accelerate drug research. Has legacy biotech clients but AI platform lacks traction. $80M market cap at $1.76.
Read full article (1 min)